1. Home
  2. SGMO vs PFD Comparison

SGMO vs PFD Comparison

Compare SGMO & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Logo Flaherty & Crumrine Preferred and Income Fund Incorporated

PFD

Flaherty & Crumrine Preferred and Income Fund Incorporated

HOLD

Current Price

$11.77

Market Cap

152.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGMO
PFD
Founded
1995
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
141.2M
152.5M
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
SGMO
PFD
Price
$0.38
$11.77
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$5.75
N/A
AVG Volume (30 Days)
4.5M
13.8K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
66.89
N/A
EPS
N/A
N/A
Revenue
$36,567,000.00
N/A
Revenue This Year
$4.79
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
88.60
N/A
52 Week Low
$0.35
$10.22
52 Week High
$1.05
$12.16

Technical Indicators

Market Signals
Indicator
SGMO
PFD
Relative Strength Index (RSI) 43.99 33.95
Support Level $0.36 $11.66
Resistance Level $0.56 $11.99
Average True Range (ATR) 0.04 0.12
MACD -0.00 -0.03
Stochastic Oscillator 12.15 13.04

Price Performance

Historical Comparison
SGMO
PFD

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated

Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: